LUCD

Lucid Diagnostics Inc. (LUCD) Economic Moat Analysis (2026)

Invetso Score: 2/10 — Weak · Last Updated: 2026-09-01

Overall Score

Profitability Returns

Returns remain deeply negative, with ROIC at -1.41%, ROE at -4.04%, and ROA at -1.34%.

Operating margins are still severely negative, with EBIT margin at -9.59% and operating margin at -9.31%.

Gross margin is negative at -25.79%, indicating the business is not yet generating positive unit economics.

Cash Generation

Free cash flow remains negative, with FCF yield at -24.99% and FCF per share at -0.26.

Operating cash flow is also negative, with OCF margin at -8.61% and OCF per share at -0.26.

Cash conversion remains weak despite a modest current ratio of 1.33.

Balance Sheet Strength

Liquidity is adequate for now, with a current ratio of 1.33 and quick ratio of 1.31.

Leverage is moderate, with debt-to-equity at 2.28 and debt-to-assets at 0.64.

Net debt is low relative to EBITDA, but EBITDA is negative, limiting the usefulness of leverage metrics.

Competitive Position

There is no evidence of durable pricing power, as margins remain deeply negative and gross margin is below zero.

The company is still in a loss-making phase, which limits proof of an economic moat.

High valuation multiples versus sales and book value suggest the market is pricing in future improvement rather than current moat strength.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Lucid Diagnostics Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →